This report highlights zonisamide as a potential cause of serious cutaneous reactions as well as its cross-reactivity with other sulfonamides. Here, we present a case of SJS-TEN due to zonisamide, which was effectively treated with IVIg. Subsequently, the patient was transitioned to levetiracetam for seizure control.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799627 | PMC |
http://dx.doi.org/10.1002/ccr3.1288 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!